US Stock MarketDetailed Quotes

RGBPP REGEN BIOPHARMA INC

Watchlist
  • 0.138
  • +0.037+36.95%
15min DelayClose Nov 13 16:00 ET
0Market Cap0.00P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
0.00%59.07K
0.00%59.07K
0.00%59.07K
0.44%236.56K
0.00%59.37K
0.59%59.07K
1.19%59.07K
0.00%59.07K
37.57%235.52K
-0.58%59.37K
Operating revenue
0.00%59.07K
0.00%59.07K
0.00%59.07K
0.44%236.56K
0.00%59.37K
0.59%59.07K
1.19%59.07K
0.00%59.07K
37.57%235.52K
-0.58%59.37K
Cost of revenue
Gross profit
Operating expense
15.82%167.03K
16.12%160.14K
-65.23%181.85K
60.58%923.51K
-24.62%118.45K
22.61%144.22K
2.26%137.91K
216.00%522.93K
54.62%575.12K
-15.76%157.15K
Selling and administrative expenses
35.59%134.53K
18.28%120K
-68.57%134.32K
137.28%711.21K
-10.51%83.12K
14.62%99.22K
43.92%101.46K
758.37%427.42K
-10.60%299.73K
-43.96%92.88K
-General and administrative expense
35.59%134.53K
18.28%120K
-68.57%134.32K
137.28%711.21K
-10.51%83.12K
14.62%99.22K
43.92%101.46K
758.37%427.42K
-10.60%299.73K
-43.96%92.88K
Research and development costs
-27.78%32.5K
10.12%40.13K
-50.24%47.53K
-22.91%212.3K
-45.02%35.34K
44.88%45K
-43.38%36.45K
-17.44%95.51K
650.29%275.39K
208.82%64.27K
Operating profit
-26.79%-107.97K
-28.19%-101.07K
73.53%-122.78K
-102.28%-686.95K
39.57%-59.09K
-44.55%-85.16K
-3.07%-78.84K
-335.87%-463.87K
-69.15%-339.61K
22.90%-97.78K
Net non-operating interest income expense
-55.68%-21.89K
-77.10%-21.4K
-27.49%-22.13K
-21.43%-309.45K
-229.83%-265.94K
73.20%-14.06K
81.24%-12.09K
69.72%-17.36K
30.53%-254.83K
33.80%-80.63K
Non-operating interest income
----
----
----
--0
----
----
----
----
97.83%455
-58.21%56
Non-operating interest expense
55.68%21.89K
77.10%21.4K
27.49%22.13K
-71.66%59.45K
-54.70%15.94K
-73.27%14.06K
-81.27%12.09K
-69.79%17.36K
-42.84%209.79K
-71.14%35.19K
Total other finance cost
----
----
----
449.45%250K
----
----
----
----
--45.5K
----
Other net income (expense)
-261
-109.68%-204.85K
-29.13%2.15M
0
100.05%35.95K
-24.63%2.12M
149.02%3.04M
108.84%100.38K
Gain on sale of security
---261
----
-109.68%-204.85K
-36.16%2.15M
--0
----
100.05%35.95K
-25.53%2.12M
162.16%3.37M
127.85%100.38K
Special income (charges)
----
----
--0
101.21%1.15K
--0
----
----
101.21%1.15K
87.75%-95.02K
--0
-Less:Other special charges
----
----
----
-101.21%-1.15K
--0
----
----
-101.21%-1.15K
-87.75%95.02K
--0
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
---237.3K
--0
Income before tax
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
Income tax
Net income
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
Net income continuous Operations
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
Minority interest income
Net income attributable to the parent company
-18.03%-117.11K
-122.77%-122.47K
-124.15%-349.76K
-54.04%1.02M
-314.66%-280.24K
-100.16%-99.22K
99.92%-54.98K
-39.42%1.45M
132.92%2.23M
95.12%-67.58K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.03%-117.11K
-122.77%-122.47K
-124.15%-349.76K
-54.04%1.02M
-314.66%-280.24K
-100.16%-99.22K
99.92%-54.98K
-39.42%1.45M
132.92%2.23M
95.12%-67.58K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue 0.00%59.07K0.00%59.07K0.00%59.07K0.44%236.56K0.00%59.37K0.59%59.07K1.19%59.07K0.00%59.07K37.57%235.52K-0.58%59.37K
Operating revenue 0.00%59.07K0.00%59.07K0.00%59.07K0.44%236.56K0.00%59.37K0.59%59.07K1.19%59.07K0.00%59.07K37.57%235.52K-0.58%59.37K
Cost of revenue
Gross profit
Operating expense 15.82%167.03K16.12%160.14K-65.23%181.85K60.58%923.51K-24.62%118.45K22.61%144.22K2.26%137.91K216.00%522.93K54.62%575.12K-15.76%157.15K
Selling and administrative expenses 35.59%134.53K18.28%120K-68.57%134.32K137.28%711.21K-10.51%83.12K14.62%99.22K43.92%101.46K758.37%427.42K-10.60%299.73K-43.96%92.88K
-General and administrative expense 35.59%134.53K18.28%120K-68.57%134.32K137.28%711.21K-10.51%83.12K14.62%99.22K43.92%101.46K758.37%427.42K-10.60%299.73K-43.96%92.88K
Research and development costs -27.78%32.5K10.12%40.13K-50.24%47.53K-22.91%212.3K-45.02%35.34K44.88%45K-43.38%36.45K-17.44%95.51K650.29%275.39K208.82%64.27K
Operating profit -26.79%-107.97K-28.19%-101.07K73.53%-122.78K-102.28%-686.95K39.57%-59.09K-44.55%-85.16K-3.07%-78.84K-335.87%-463.87K-69.15%-339.61K22.90%-97.78K
Net non-operating interest income expense -55.68%-21.89K-77.10%-21.4K-27.49%-22.13K-21.43%-309.45K-229.83%-265.94K73.20%-14.06K81.24%-12.09K69.72%-17.36K30.53%-254.83K33.80%-80.63K
Non-operating interest income --------------0----------------97.83%455-58.21%56
Non-operating interest expense 55.68%21.89K77.10%21.4K27.49%22.13K-71.66%59.45K-54.70%15.94K-73.27%14.06K-81.27%12.09K-69.79%17.36K-42.84%209.79K-71.14%35.19K
Total other finance cost ------------449.45%250K------------------45.5K----
Other net income (expense) -261-109.68%-204.85K-29.13%2.15M0100.05%35.95K-24.63%2.12M149.02%3.04M108.84%100.38K
Gain on sale of security ---261-----109.68%-204.85K-36.16%2.15M--0----100.05%35.95K-25.53%2.12M162.16%3.37M127.85%100.38K
Special income (charges) ----------0101.21%1.15K--0--------101.21%1.15K87.75%-95.02K--0
-Less:Other special charges -------------101.21%-1.15K--0---------101.21%-1.15K-87.75%95.02K--0
Other non- operating income (expenses) -----------------------------------237.3K--0
Income before tax -31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K
Income tax
Net income -31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K
Net income continuous Operations -31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K
Minority interest income
Net income attributable to the parent company -18.03%-117.11K-122.77%-122.47K-124.15%-349.76K-54.04%1.02M-314.66%-280.24K-100.16%-99.22K99.92%-54.98K-39.42%1.45M132.92%2.23M95.12%-67.58K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.03%-117.11K-122.77%-122.47K-124.15%-349.76K-54.04%1.02M-314.66%-280.24K-100.16%-99.22K99.92%-54.98K-39.42%1.45M132.92%2.23M95.12%-67.58K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data